Search the Newsreel

Enanta Pharma reports $19.5 million Q3 loss, advances RSV pipeline

Enanta Pharmaceuticals reported a net loss of $19.5 million for Q3 FY26, with revenue dropping 21% year-over-year to $14.4 million, missing analyst estimates. Despite financial setbacks, the company advanced its RSV pipeline, initiating the LOTUS pediatric trial and preparing for the RESOLVE adult trial. …

LifeVantage CEO, director Terrence Moorehead files initial beneficial ownership statement

LifeVantage CEO and director Terrence Moorehead has filed an initial Form 3, formally identifying him as the company's president, CEO, and director. This news brief was generated by AI based on original content published by LifeVantage Corporation via EDGAR on August 10, 2026.

Enanta Pharmaceuticals (ENTA) Reports Q3 Loss, Lags Revenue Estimates

Enanta Pharmaceuticals (ENTA) reported a Q3 loss of $0.67 per share, significantly missing the Zacks Consensus Estimate of a $0.37 loss, and its revenues of $14.36 million also fell short of expectations. Despite exceeding EPS estimates three times in the last four quarters, the …

Quanta Services Posted a Record Quarter and a $53 Billion Backlog. Why Is the Stock Cheaper Than in May?

Quanta Services (PWR) experienced a significant stock drop before its Q2 report due to investor concerns, but then saw a double-digit jump after announcing record Q2 results, including a 41% revenue increase, 71% adjusted EPS climb, and a $53 billion backlog. Despite the recovery, …

First Advantage (FA) Stock May Be Below Fair Value After Raised Guidance

First Advantage (FA) stock has seen a significant return over three years, but its valuation signals are mixed. A Discounted Cash Flow (DCF) analysis suggests the stock is undervalued, indicating the market is valuing it below its potential cash flows. However, using the Price-to-Sales …

Lifevantage Corp (LFVN) grants CEO Terrence Moorehead 848,765 stock and PRSU units

Lifevantage Corp (LFVN) granted its President and CEO, Terrence Moorehead, equity awards totaling 848,765 units on August 6, 2026. This includes 308,642 shares of common stock as a stock unit award, vesting in three equal installments from 2027 to 2029, and 540,123 Performance Restricted …

First Advantage Announces Launch of Secondary Offering of Common Stock

First Advantage Corporation ATLANTA, Aug. 10, 2026 (GLOBE NEWSWIRE) -- First Advantage Corporation ("First Advantage") (NASDAQ: FA), a global software and data company providing comprehensive, end-to-end identity solutions, criminal background screening, credential verifications, drug and health screening, and continuous risk monitoring, today announced that …

Silver Lake Funds Plan to Sell 12.5M First Advantage Shares

Investment funds associated with Silver Lake Group intend to sell 12.5 million common shares of First Advantage (NASDAQ: FA) in an underwritten secondary offering. First Advantage will not sell any shares or receive any proceeds from this sale; all proceeds will go to the …

Enanta Pharma misses Q3 estimates on lower royalty revenue By Investing.com

Enanta Pharmaceuticals reported third-quarter results that fell short of analyst expectations, with adjusted earnings per share of -$0.67 and revenue of $14.4 million, missing estimates of -$0.50 and $17.4 million, respectively. This underperformance was primarily due to lower royalty revenue from AbbVie’s hepatitis C …

Enanta Fiscal Q3 2026 Earnings: Higher Royalty-Related Interest Expense Widens Net Loss

Enanta Pharmaceuticals reported a 21.6% decline in fiscal Q3 2026 revenue to $14.4 million due to lower MAVYRET/MAVIRET royalties. Despite narrowed operating losses from reduced clinical trial spending, the net loss widened to $19.5 million because of increased royalty-related interest expenses. The company holds …

Enanta Pharmaceuticals (NASDAQ:ENTA) Posts Earnings Results, Misses Expectations By $0.16 EPS

Enanta Pharmaceuticals (NASDAQ:ENTA) reported a quarterly loss of $0.67 per share, missing analyst estimates by $0.16. The biotechnology company also showed negative return on equity and net margin. Despite the earnings miss, the stock rose 0.3% during Monday trading, and institutional investors hold a …

Enanta Pharmaceuticals reports Q3 loss; revenue $14.4M, cash and securities $211.5M

Enanta Pharmaceuticals reported a Q3 fiscal year loss of $19.5 million on revenue of $14.4 million, with $211.5 million in cash and marketable securities. The company expects current resources to fund operations into fiscal 2029 and highlighted progress in its virology and immunology programs, …

Santander Plans Share Buyback of Up to $2.1 Billion

Banco Santander (SAN) plans to initiate a share buyback program totaling up to 1.825 billion euros ($2.11 billion) to reduce its share capital. This program could involve repurchasing up to 1.47 billion shares, with the start date set for August 24 and continuing until …

Quanta Services Inc. stock outperforms competitors despite losses on the day

Shares of Quanta Services Inc. (PWR) fell 1.64% to $660.86 on Monday, performing better than the overall market decline where the S&P 500 Index (SPX) dropped 0.06% and the Dow Jones Industrial Average (DJIA) fell 0.11%. Despite the daily loss, the company's stock still …

Banco Santander (SAN) sets EUR 1.83B buyback tied to H1 2026 profit

REG - Banco Santander S.A. - Commencement of a program to repurchase own shares

Banco Santander, S.A. (SAN) announced the commencement of a share repurchase program worth EUR 1,825 million, which is approximately 25% of the Group's underlying profit in the first half of 2026. This program aligns with the bank's shareholder remuneration policy, targeting 50% of underlying …

Why Novanta (NOVT) Is Up 16.7% After Q2 Results And Its Largest Medical Acquisition

Novanta Inc. (NOVT) reported strong Q2 2026 results, with sales of US$265.81 million and net income of US$12.54 million, leading to a 16.7% stock increase. The company's largest acquisition to date, Riverpoint Medical, significantly expands its medical market presence and recurring consumables business. This …

Santacruz Silver Mining Ltd. Revenue Breakdown – LSX:A41S50

Santacruz Silver Mining Ltd. (LSX:A41S50) generated €277.89 million in revenue last year. The Zimapan segment was the top-performing segment, contributing €88.75 million, an increase from €75.12 million the previous year. Geographically, Bolivia was the largest contributor to revenue, accounting for €194.01 million.

FA Q2 Deep Dive: AI-Driven Solutions, Enterprise Wins, and Guidance Raise Shape Outlook

FA Q2 Deep Dive: AI-Driven Solutions, Enterprise Wins, and Guidance Raise Shape Outlook Background screening provider First Advantage (NASDAQ:FA) reported Q2 CY2026 results topping the market's revenue expectations , with sales up 14.9% year on year to $448.8 million. The company's full-year revenue guidance …

Sei Investments Co. Buys 45,608 Shares of First Advantage Co. $FA

First Advantage Co. $FA Shares Acquired by Quantinno Capital Management LP

NOVT Q2 Deep Dive: Acquisition and Manufacturing Moves Drive Outlook Higher

NOVT Q2 Deep Dive: Acquisition and Manufacturing Moves Drive Outlook Higher Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) beat Wall Street's revenue expectations in Q2 CY2026, with sales up 10.3% year on year to $265.8 million. On top of that, next quarter's revenue guidance …

Cantabil Retail Standalone June 2026 Net Sales at Rs 178.82 crore, up 12.7% Y-o-Y

Santana Minerals (ASX:SMI) Advances Bendigo-Ophir Gold Project Toward December Approval

Banco Santander Brasil SA (BSBR) Earnings Forecast: Future EPS & Revenue Growth Estimates

Cantabil Retail posts 13% revenue rise, 33.21% EBITDA margin in Q1FY27

Weekly Recap: Webster takeover approval and €4.392bn buyback

Banco Santander S.A. is moving forward with a significant Webster Financial takeover, aiming for ~18% ROTCE and 7–8% EPS accretion. Concurrently, the company completed a €4.392bn share buyback, representing approximately 17.7% of outstanding shares. Separately, unions have initiated redundancy talks following Santander's £2.65bn acquisition …

Should Atlanta Braves Holdings' Rising Sales But Deepening Losses Reshape the BATR.K Investment Narrative?

Banco Santander, S.A. (SAN.BA) Analyst insights, Price targets and Recommendations

The article provides analyst insights, price targets, and recommendations for Banco Santander, S.A. (SAN.BA). It displays current stock information including its price, daily change, and closing time from the Buenos Aires exchange. The page also includes various market data and trending tickers.

Quantinno Capital Management LP Boosts Stake in Atlanta Braves Holdings, Inc. $BATRA

Quantinno Capital Management LP significantly increased its stake in Atlanta Braves Holdings, Inc. (NASDAQ:BATRA) by 45.6% in the first quarter, now holding 63,272 shares valued at approximately $2.98 million. Despite this, analyst sentiment remains cautious, with an average "Reduce" rating for BATRA, and the …

Quanta Services, Inc. (PWR) Stock Forecasts

Argus projects earnings growth for Quanta Services, Inc. (PWR) due to its involvement in transmission projects and data centers. The company provides infrastructure solutions across various industries, including utility, clean energy, communications, and energy. Argus currently has a price target of $671.86 for PWR …

Is First Advantage (FA) Still Worth A Look On Raised Guidance And Strong Earnings?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. First Advantage (FA) is back in focus after its latest earnings release, an increase in its 2026 revenue guidance, and an update on …

Galantas Gold triples Indiana drill campaign on new mineralization indications

Banco Santander-Chile (BSAC) Earnings Forecast: Future EPS & Revenue Growth Estimates

Quanta Services Inc (PWR) Stock News Today

This article provides a list of recent news headlines for Quanta Services Inc (PWR) stock, detailing daily price movements and their reported drivers. It shows several instances where PWR stock moved up or down by significant percentages, along with the dates of these movements.

Banco Santander Chile (NYSE:BSAC) Receives Consensus Recommendation of "Moderate Buy" from Brokerages